Catalyst Wire Dossier Catalyst Wire Dossier

Everolimus (Afinitor)

everolimus · Novartis
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Everolimus (Afinitor), covering 2012-12-24 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient [NA]

See pricing